{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:52:19Z","timestamp":1753883539069,"version":"3.41.2"},"reference-count":25,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"11","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n            <jats:title>PURPOSE<\/jats:title>\n            <jats:p>Comorbidities adversely affect the prognosis of several low-grade B-cell lymphomas, yet their influence in Waldenstr\u00f6m macroglobulinemia (WM) remains unexplored. This study aimed to comprehensively evaluate the clinical characteristics, treatment landscape, and survival outcomes in patients with WM, with a specific focus on the prognostic significance of comorbidities in an Asian cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>This retrospective analysis included patients with WM from September 2002 to September 2023 using the Integrative Medical Data Center of National Taiwan University Hospital database. The primary end points were survival data stratified by prognostic factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>\n              A total of 135 patients with WM were included, with a median age of 66.8 years. Sixty-eight percent had at least one comorbidity, with a median Charlson comorbidity index score of 5.5. The median overall survival (OS) was 9.2 years. Multivariable analysis revealed that high-risk International Prognostic Scoring System for Waldenstr\u00f6m macroglobulinemia (IPSSWM; hazard ratio [HR], 3.84 [95% CI, 1.14 to 13.0];\n              <jats:italic>P<\/jats:italic>\n              = .03) was significantly associated with a poor OS, while cytogenetic abnormalities (HR, 2.10 [95% CI, 0.92 to 4.82];\n              <jats:italic>P<\/jats:italic>\n              = .08) and a high comorbidity burden (HR, 1.90 [95% CI, 0.96 to 3.74];\n              <jats:italic>P<\/jats:italic>\n              = .065) demonstrated a notable trend toward worse outcomes. Among patients without anti\u2013hepatitis B virus (HBV) prophylaxis, 100% of the HBV carriers experienced reactivation, compared with 17.5% of those with remote HBV infections.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Real-world WM data were used to validate the prognostic value of IPSSWM and revised IPSSWM in an Asian population. High comorbidity burden was associated with a poor survival, and the need for HBV prophylaxis was disclosed in patients with a history of HBV infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1200\/go-24-00576","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T19:59:20Z","timestamp":1744401560000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Comorbidities on Patients With Waldenstr\u00f6m Macroglobulinemia in Taiwan: A Multicenter Study"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4571-3328","authenticated-orcid":true,"given":"Yu-Sung","family":"Chang","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hsuan","family":"Tuan","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Wei","family":"Gao","sequence":"additional","affiliation":[{"name":"Cancer Registry, Cancer Administration and Coordination Center, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4625-0534","authenticated-orcid":true,"given":"Chao-Hung","family":"Wei","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Ju","family":"Chiu","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Department of Hematological Oncology, National Taiwan University Cancer Center Branch, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4894-9306","authenticated-orcid":true,"given":"Ta-Chuan","family":"Yu","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1625-7295","authenticated-orcid":true,"given":"Tai-Chung","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26796"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2023.03.008"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30087-5"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-848044"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2023.03.020"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2023.03.009"},{"key":"e_1_3_6_8_2","volume-title":"ISCN 2020 an International System for Human Cytogenomic Nomenclature 2020: Recommendations of the International Standing Committee on Human Cytogenomic Nomenclature Including Revised Sequence-Based Cytogenomic Nomenclature Developed in Collaboration with the Human Genome Variation Society (HGVS) Sequence Variant Description Working Group","author":"International Standing Committee on Human Cytogenomic Nomenclature","year":"2020","unstructured":"International Standing Committee on Human Cytogenomic Nomenclature; McGowan-Jordan J, Hastings RJ, et al: ISCN 2020 an International System for Human Cytogenomic Nomenclature 2020: Recommendations of the International Standing Committee on Human Cytogenomic Nomenclature Including Revised Sequence-Based Cytogenomic Nomenclature Developed in Collaboration with the Human Genome Variation Society (HGVS) Sequence Variant Description Working Group. Basel, Switzerland, Karger, 2020"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-017-0332-6"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2427"},{"key":"e_1_3_6_12_2","first-page":"15657","article-title":"Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: A primer for practitioners","volume":"367","author":"Desai RJ","year":"2019","unstructured":"Desai RJ, Franklin JM: Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: A primer for practitioners. BMJ 367:15657, 2019","journal-title":"BMJ"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.100784"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1938030"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0001"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy322"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.070458"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06389.x"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-174961"},{"key":"e_1_3_6_20_2","article-title":"Treatment and survival outcomes of Waldenstrom macroglobulinemia in Latin American patients: A multinational retrospective cohort study","author":"Riva E","unstructured":"Riva E, Duarte PJ, Valc\u00e1rcel B, et al: Treatment and survival outcomes of Waldenstrom macroglobulinemia in Latin American patients: A multinational retrospective cohort study. JCO Glob Oncol 10.1200\/GO.21.00380","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0431-y"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-01018-6"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04470-7"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3993"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.7081"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10239-x"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-24-00576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T19:59:23Z","timestamp":1744401563000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-24-00576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1200\/GO-24-00576"],"URL":"https:\/\/doi.org\/10.1200\/go-24-00576","relation":{},"ISSN":["2687-8941"],"issn-type":[{"type":"electronic","value":"2687-8941"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-11-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2400576"}}